NPPA\'s U-turn on capping prices of 108 drugs for cardiac, diabetes  

September 30, 2014

First, the drug regulator issued guidelines to control prices of drugs that were outside the list of essential drugs. When pharma companies reached court, NPPA withdrew its guidelines through a notification

Moneylife Digital Team

The National Pharmaceutical Pricing Authority (NPPA) has withdrawn guidelines it issued for price control on 108 drugs used in treatment of cardiac and diabetes.

To read more on this click here